GSK completes travel vaccine offload as revamp continuesGlaxoSmithKline’s last act of 2019 was the completion of its near-€1 billion deal to divest two vaccines to Share XGSK completes travel vaccine offload as revamp continueshttps://pharmaphorum.com/news/gsk-completes-travel-vaccine-offload-as-revamp-continues/
GSK sells travel vaccines to Bavarian NordicGlaxoSmithKline (GSK) has sold off two travel vaccines to Bavarian Nordic, as the company shifts its focus away Share XGSK sells travel vaccines to Bavarian Nordichttps://pharmaphorum.com/news/gsk-sells-travel-vaccines-to-bavarian-nordic/
Janssen and Bavarian Nordic sign $836m deal on Hep B and HIV vaccinesJanssen has signed a new deal with Bavarian Nordic worth up to $836 million to develop target vaccines Share XJanssen and Bavarian Nordic sign $836m deal on Hep B and HIV vaccineshttps://pharmaphorum.com/news/janssen-bavarian-nordic-sign-836m-deal-hep-b-hiv-vaccines/
BMS looks to Opdivo + vaccine combo for non-PD-L1 lung cancer patientsBristol-Myers Squibb is teaming up with France’s Transgene to combine Opdivo with investigational therapeutic vaccine TG4010 in lung Share XBMS looks to Opdivo + vaccine combo for non-PD-L1 lung cancer patientshttps://pharmaphorum.com/news/bms-looks-opdivo-cancer-vaccine-combination-regain-ground-nsclc/
